BMT CLINICAL TRIALS NETWORK AML T Cell Depletion Protocol[removed]Version 7.0 dated November 13, 2006 PROTOCOL SYNOPSIS – BMT CTN PROTOCOL 0303 - Leukapheresis - Document - PDFSEARCH.IO

First Page		Document Content
Transfusion medicine Alkylating antineoplastic agents Myeloid leukemia Acute myeloid leukemia Graft-versus-host disease Leukapheresis Anti-thymocyte globulin CD34 Hematopoietic stem cell transplantation Medicine Transplantation medicine Hematology		BMT CLINICAL TRIALS NETWORK AML T Cell Depletion Protocol[removed]Version 7.0 dated November 13, 2006 PROTOCOL SYNOPSIS – BMT CTN PROTOCOL 0303 Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 116,58 KB Share Document on Facebook

	Boswellic acid acetate induces apoptosis through caspase-mediated pathways in myeloid leukemia cells Lijuan Xia, Duo Chen, Rui Han, et al. Mol Cancer Ther 2005;4:Updated version DocID: 1v6bB - View Document
	The Dual E-selectin/CXCR4 Antagonist GMI-1359 Exerts Anti-leukemia Efficacy Against FLT3-ITDmutated Acute Myeloid Leukemia in A Patient-derived Xenograft Murine Model Mouse-1 Mouse-2 DocID: 1uSbg - View Document
$A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan$	A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan DocID: 1uJQ2 - View Document
	Platelet Proteomics in Chronic Myeloid Leukemia DocID: 1uEkU - View Document
	Vascular E-Selectin Mediates Chemo-Resistance in Acute Myeloid Leukemia Initiating Cells Via Canonical Receptors PSGL-1 (CD162) and Hcell (CD44) and AKT Signaling Ingrid G Winkler, PhD1, Johanna M Erbani, PhD student2, DocID: 1u5Xi - View Document